I agree that this site is using cookies. You can find further informations here.
X
Shafaee, Maryam Nemati
25  results:
Search for persons X
?
1

Identifying biomarkers of differential chemotherapy respons..:

Petrosyan, Varduhi ; Dobrolecki, Lacey E. ; Thistlethwaite, Lillian...
iScience.  26 (2023)  1 - p. 105799 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Breast Cancer Treatment Delay in SafetyNet Health Systems, ..:

Shafaee, Maryam Nemati ; Silva, Leonardo Roberto ; Ramalho, Susana...
The Oncologist.  27 (2022)  5 - p. 344-351 , 2022
Link: https://doi.org/10.1093/..
 
?
3

Concurrent Chemo-radiation As a Means of Achieving Patholog..:

Shafaee, Maryam Nemati ; Makawita, Shalini ; Lim, Bora..
Clinical Breast Cancer.  22 (2022)  4 - p. e536-e543 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Dose-reduced trastuzumab deruxtecan can be safely used in l..:

Higashiyama, Nicole ; Nangia, Julie ; Shafaee, Maryam Nemati...
Current Problems in Cancer: Case Reports.  2 (2020)  - p. 100034 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Surgery for CNS Tumors in the Brazilian National Health Car..:

Pontes, Luciola ; Shafaee, Maryam Nemati ; Haaland, Benjamin.
Journal of Global Oncology.  3 (2017)  2 - p. 157-161 , 2017
Link: https://doi.org/10.1200/..
 
?
6

Editorial: Breast Cancer Patient-Derived Xenografts: Pros, ..:

Shafaee, Maryam Nemati ; Ellis, Matthew James
JNCI: Journal of the National Cancer Institute.  109 (2017)  7 - p. , 2017
Link: https://doi.org/10.1093/..
 
?
7

Aromatase inhibitors and contralateral breast cancer in BRC..:

Nemati Shafaee, Maryam ; Goutsouliak, Kristina ; Lin, Heather...
Breast Cancer Research and Treatment.  196 (2022)  1 - p. 143-152 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Proteogenomic Markers of Chemotherapy Resistance and Respon..:

Anurag, Meenakshi ; Jaehnig, Eric J. ; Krug, Karsten...
Cancer Discovery.  12 (2022)  11 - p. 2586-2605 , 2022
Link: https://doi.org/10.1158/..
 
?
9

Identifying biomarkers of differential chemotherapy respons..:

Petrosyan, Varduhi ; Dobrolecki, Lacey E ; Thistlethwaite, Lillian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813793/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Dose-reduced trastuzumab deruxtecan can be safely used in l..:

Higashiyama, Nicole ; Nangia, Julie ; Shafaee, Maryam Nemati...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425325/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

Neurofibromin is an Estrogen Receptor-α Transcriptional Co-..:

Zheng, Ze-Yi ; Anurag, Meenakshi ; Lei, Jonathan T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286719/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

Surgery for CNS Tumors in the Brazilian National Health Car..:

Pontes, Luciola ; Shafaee, Maryam Nemati ; Haaland, Benjamin.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493277/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
13

Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab..:

Maiti, Abhishek ; Nemati-Shafaee, Maryam ; Msaouel, Pavlos...
Clinical Genitourinary Cancer.  16 (2018)  1 - p. e47-e57 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Identifying biomarkers of differential chemotherapy respons..:

Varduhi Petrosyan ; Lacey E. Dobrolecki ; Lillian Thistlethwaite...
http://www.sciencedirect.com/science/article/pii/S2589004222020727.  , 2023
Link: https://doi.org/10.1016/..
 
?
15

Proteogenomic Markers of Chemotherapy Resistance and Respon..:

Anurag, Meenakshi ; Jaehnig, Eric J ; Krug, Karsten...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627136/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15